e-drug
[Top] [All Lists]

E-DRUG: Asthenia as indication & side-effects of L-carnitine

Jerome,

I don't have much info on carnitine, other than Meylers and Martindale,
which you have.  But, I do suggest that you put out the call for
information on the ANCHODD list, and perhaps the sci.med.pharmacy
newsgroup.  Both hit a slightly different audience than e-drug.  The
general info on ANCHODD, excerpted from their instruction message
sent to all subscribers, is  shown below.

Good luck,

Jim Rankin, Management Sciences for Health
jrankin@msh-dc.org 

----

L-carnitine is not marketed in Canada as a drug.  DL carnitine is available
in health food stores.  It is promoted to increase athletic performance.

Joel Lexchin

Joel Lexchin MD
121 Walmer Rd.
Toronto, Ontario
CANADA M5R 2X8
Phone:  (416)-964-7186
Fax:  (416)-923-9515

---
Note from the moderator:

For 'technical' pharmaceutical questions, one can also use PHARMWEB.
The subscription info for ANCHODD is below - in principle it is similar to
E-drug

Wilbert Bannenberg, E-drug moderator
-----

OVERVIEW OF ANCHODD:
The purpose of ANCHODD is to provide you with a rapid means of
contacting other drug scientists and exchanging information with them.  

Messages sent to <anchodd@postoffice.utas.edu.au> are forwarded to
all subscribers, of whom there are approximately 500 throughout the
world.  ANCHODD is moderated, which means that messages to the list
must be forwarded by the list owner.  This is mainly to prevent the
development of troublesome loops, which can produce large numbers of
"returned mail" messages".

Please feel free to use ANCHODD for any worthwhile purpose, provided
only that it is relevant to the goal of promoting drug research in the
widest possible sense.  This includes drug discovery and development,
as well as basic and applied/clinical studies in pharmacology, medicinal
chemistry and toxicology.  Apart from requests for assistance, and
offers of services,  ANCHODD can be used to carry announcements and
general news items.

SUBSCRIPTION INFO:

These commands must be sent to <majordomo@postoffice.utas.edu.au>
(NOT to <anchodd@postoffice.utas.edu.au>).

In the description below items contained in []'s are optional. if you are
including the item, do not include the []'s around it.

To subscribe:

subscribe anchodd [your address]

To unsubscribe:

unsubscribe list [address]

Other standard commands are provided when you join ANCHODD

--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.

<Prev in Thread] Current Thread [Next in Thread>
  • E-DRUG: Asthenia as indication & side-effects of L-carnitine, JIM RANKIN <=